2seventy bio Inc. (NASDAQ: TSVT)
$2.9900
+0.0700 ( +4.18% ) 189.0K
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.
Market Data
Open
$2.9900
Previous close
$2.9200
Volume
189.0K
Market cap
$155.75M
Day range
$2.8750 - $3.0430
52 week range
$2.7800 - $6.4000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Dec 17, 2024 |
| 4 | Insider transactions | 1 | Nov 20, 2024 |
| 8-k | 8K-related | 37 | Nov 12, 2024 |
| 10-q | Quarterly Reports | 80 | Nov 12, 2024 |
| 8-k | 8K-related | 13 | Oct 31, 2024 |
| 4 | Insider transactions | 1 | Oct 07, 2024 |
| 4 | Insider transactions | 1 | Oct 07, 2024 |
| 8-k | 8K-related | 38 | Sep 25, 2024 |
| 4 | Insider transactions | 1 | Aug 16, 2024 |
| 10-q | Quarterly Reports | 81 | Aug 08, 2024 |